This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, M.
Right arrow Articles by Wolff, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, M.
Right arrow Articles by Wolff, L.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 2000, p. 1970-1981, Vol. 20, No. 6
0270-7306/00/$04.00+0

Regulation of the Resident Chromosomal Copy of c-myc by c-Myb Is Involved in Myeloid Leukemogenesis

M. Schmidt,1 V. Nazarov,1,dagger L. Stevens,2 R. Watson,3 and L. Wolff1,*

Laboratory of Cellular Oncology1 and Laboratory of Genetics,2 National Cancer Institute, Bethesda, Maryland, and Ludwig Institute for Cancer Research, Imperial College School of Medicine at St. Mary's, London, United Kingdom3

Received 13 October 1999/Returned for modification 12 November 1999/Accepted 16 December 1999

c-myb is a frequent target of retroviral insertional mutagenesis in murine leukemia virus-induced myeloid leukemia. Induction of the leukemogenic phenotype is generally associated with inappropriate expression of this transcriptional regulator. Despite intensive investigations, the target genes of c-myb that are specifically involved in development of these myeloid lineage neoplasms are still unknown. In vitro assays have indicated that c-myc may be a target gene of c-Myb; however, regulation of the resident chromosomal gene has not yet been demonstrated. To address this question further, we analyzed the expression of c-myc in a myeloblastic cell line, M1, expressing a conditionally active c-Myb-estrogen receptor fusion protein (MybER). Activation of MybER both prevented the growth arrest induced by interleukin-6 (IL-6) and rapidly restored c-myc expression in nearly terminal differentiated cells that had been exposed to IL-6 for 3 days. Restoration occurred in the presence of a protein synthesis inhibitor but not after a transcriptional block, indicating that c-myc is a direct, transcriptionally regulated target of c-Myb. c-myc is a major target that transduces Myb's proliferative signal, as shown by the ability of a c-Myc-estrogen receptor fusion protein alone to also reverse growth arrest in this system. To investigate the possibility that this regulatory connection contributes to Myb's oncogenicity, we expressed a dominant negative Myb in the myeloid leukemic cell line RI-4-11. In this cell line, c-myb is activated by insertional mutagenesis and cannot be effectively down regulated by cytokine. Myb's ability to regulate c-myc's expression was also demonstrated in these cells, showing a mechanism through which the proto-oncogene c-myb can exert its oncogenic potential in myeloid lineage hematopoietic cells.


* Corresponding author. Mailing address: Laboratory of Cellular Oncology, National Cancer Institute, Bldg. 37, Rm. 2D11, 37 Convent Dr. MSC 4255, Bethesda, MD 20892-4255. Phone: (301) 496-6763. Fax: (301) 594-3996. E-mail: lwolff{at}helix.nih.gov.

dagger Present address: Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia.


Molecular and Cellular Biology, March 2000, p. 1970-1981, Vol. 20, No. 6
0270-7306/00/$04.00+0



This article has been cited by other articles:

  • Lidonnici, M. R., Corradini, F., Waldron, T., Bender, T. P., Calabretta, B. (2008). Requirement of c-Myb for p210BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis. Blood 111: 4771-4779 [Abstract] [Full Text]  
  • Drabsch, Y., Hugo, H., Zhang, R., Dowhan, D. H., Miao, Y. R., Gewirtz, A. M., Barry, S. C., Ramsay, R. G., Gonda, T. J. (2007). Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc. Natl. Acad. Sci. USA 104: 13762-13767 [Abstract] [Full Text]  
  • Saether, T., Berge, T., Ledsaak, M., Matre, V., Alm-Kristiansen, A. H., Dahle, O., Aubry, F., Gabrielsen, O. S. (2007). The Chromatin Remodeling Factor Mi-2{alpha} Acts as a Novel Co-activator for Human c-Myb. J. Biol. Chem. 282: 13994-14005 [Abstract] [Full Text]  
  • Nakata, Y., Shetzline, S., Sakashita, C., Kalota, A., Rallapalli, R., Rudnick, S. I., Zhang, Y., Emerson, S. G., Gewirtz, A. M. (2007). c-Myb Contributes to G2/M Cell Cycle Transition in Human Hematopoietic Cells by Direct Regulation of Cyclin B1 Expression. Mol. Cell. Biol. 27: 2048-2058 [Abstract] [Full Text]  
  • Tanikawa, J., Nomura, T., Macmillan, E. M., Shinagawa, T., Jin, W., Kokura, K., Baba, D., Shirakawa, M., Gonda, T. J., Ishii, S. (2004). p53 Suppresses c-Myb-induced trans-Activation and Transformation by Recruiting the Corepressor mSin3A. J. Biol. Chem. 279: 55393-55400 [Abstract] [Full Text]  
  • Kanei-Ishii, C., Nomura, T., Tanikawa, J., Ichikawa-Iwata, E., Ishii, S. (2004). Differential Sensitivity of v-Myb and c-Myb to Wnt-1-induced Protein Degradation. J. Biol. Chem. 279: 44582-44589 [Abstract] [Full Text]  
  • Shetzline, S. E., Rallapalli, R., Dowd, K. J., Zou, S., Nakata, Y., Swider, C. R., Kalota, A., Choi, J. K., Gewirtz, A. M. (2004). Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. Blood 104: 1833-1840 [Abstract] [Full Text]  
  • Schmidt, M., Bies, J., Tamura, T., Ozato, K., Wolff, L. (2004). The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15Ink4b in murine myeloid cells. Blood 103: 4142-4149 [Abstract] [Full Text]  
  • Nomura, T., Tanikawa, J., Akimaru, H., Kanei-Ishii, C., Ichikawa-Iwata, E., Khan, M. M., Ito, H., Ishii, S. (2004). Oncogenic Activation of c-Myb Correlates with a Loss of Negative Regulation by TIF1{beta} and Ski. J. Biol. Chem. 279: 16715-16726 [Abstract] [Full Text]  
  • Kanei-Ishii, C., Ninomiya-Tsuji, J., Tanikawa, J., Nomura, T., Ishitani, T., Kishida, S., Kokura, K., Kurahashi, T., Ichikawa-Iwata, E., Kim, Y., Matsumoto, K., Ishii, S. (2004). Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev. 18: 816-829 [Abstract] [Full Text]  
  • McConnell, M. J., Chevallier, N., Berkofsky-Fessler, W., Giltnane, J. M., Malani, R. B., Staudt, L. M., Licht, J. D. (2003). Growth Suppression by Acute Promyelocytic Leukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression. Mol. Cell. Biol. 23: 9375-9388 [Abstract] [Full Text]  
  • Kumar, A., Lee, C. M., Reddy, E. P. (2003). c-Myc Is Essential but Not Sufficient for c-Myb-mediated Block of Granulocytic Differentiation. J. Biol. Chem. 278: 11480-11488 [Abstract] [Full Text]  
  • Hanlon, L., Barr, N. I., Blyth, K., Stewart, M., Haviernik, P., Wolff, L., Weston, K., Cameron, E. R., Neil, J. C. (2002). Long-Range Effects of Retroviral Insertion on c-myb: Overexpression May Be Obscured by Silencing during Tumor Growth In Vitro. J. Virol. 77: 1059-1068 [Abstract] [Full Text]  
  • Haviernik, P., Festin, S. M., Opavsky, R., Koller, R. P., Barr, N. I., Neil, J. C., Wolff, L. (2002). Linkage on chromosome 10 of several murine retroviral integration loci associated with leukaemia. J. Gen. Virol. 83: 819-827 [Abstract] [Full Text]  
  • Luger, S. M., O'Brien, S. G., Ratajczak, J., Ratajczak, M. Z., Mick, R., Stadtmauer, E. A., Nowell, P. C., Goldman, J. M., Gewirtz, A. M. (2002). Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study. Blood 99: 1150-1158 [Abstract] [Full Text]  
  • Nicot, C., Mahieux, R., Pise-Masison, C., Brady, J., Gessain, A., Yamaoka, S., Franchini, G. (2001). Human T-Cell Lymphotropic Virus Type 1 Tax Represses c-Myb-Dependent Transcription through Activation of the NF-{kappa}B Pathway and Modulation of Coactivator Usage. Mol. Cell. Biol. 21: 7391-7402 [Abstract] [Full Text]  
  • Berge, T., Bergholtz, S. L., Andersson, K. B., Gabrielsen, O. S. (2001). A novel yeast system for in vivo selection of recognition sequences: defining an optimal c-Myb-responsive element. Nucleic Acids Res 29: e99-e99 [Abstract] [Full Text]  
  • Zhao, F., Vilardi, A., Neely, R. J., Choi, J. K. (2001). Promotion of Cell Cycle Progression by Basic Helix-Loop-Helix E2A. Mol. Cell. Biol. 21: 6346-6357 [Abstract] [Full Text]  
  • Lee, Y. T., Miller, L. D., Gubin, A. N., Makhlouf, F., Wojda, U., Barrett, A. J., Liu, E. T., Miller, J. L. (2001). Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arrays. Blood 98: 1914-1921 [Abstract] [Full Text]  
  • Johansen, L. M., Iwama, A., Lodie, T. A., Sasaki, K., Felsher, D. W., Golub, T. R., Tenen, D. G. (2001). c-Myc Is a Critical Target for C/EBP{alpha} in Granulopoiesis. Mol. Cell. Biol. 21: 3789-3806 [Abstract] [Full Text]